US Stock MarketDetailed Quotes

C4 Therapeutics (CCCC)

Watchlist
  • 2.535
  • -0.295-10.42%
Close Apr 10 16:00 ET
  • 2.510
  • -0.025-0.98%
Post 19:59 ET
247.36MMarket Cap-2.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

C4 Therapeutics (CCCC) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-51.47%-98.69M
-23.49%-22.15M
-29.31%-31.21M
-142.40%-12.06M
-83.71%-33.29M
39.01%-65.16M
25.31%-17.93M
21.41%-24.13M
73.82%-4.97M
45.30%-18.12M
Net income from continuing operations
0.31%-104.99M
40.75%-20.49M
-30.41%-32.17M
-46.87%-26.02M
7.19%-26.32M
20.51%-105.32M
0.52%-34.57M
8.77%-24.67M
50.68%-17.72M
18.46%-28.36M
Depreciation and amortization
7.76%1.96M
-10.83%428K
4.07%460K
37.28%615K
1.79%456K
-3.30%1.82M
11.63%480K
-1.12%442K
-2.18%448K
-17.80%448K
Other non cash items
1,550.00%99K
144.68%21K
-3.23%30K
-80.53%22K
128.57%26K
-98.76%6K
-9.30%-47K
-69.90%31K
-47.20%113K
-143.75%-91K
Change In working capital
-482.87%-29.28M
-190.00%-6.68M
-78.11%-16.03M
23.50%7.25M
-511.62%-13.82M
210.23%7.65M
118.13%7.42M
33.31%-9M
-37.41%5.87M
153.97%3.36M
-Change in receivables
-91.94%701K
-42.80%4.14M
52.68%-4.34M
-53.13%5.83M
-173.82%-4.93M
184.22%8.7M
164.06%7.24M
-1,837.50%-9.17M
2,586.20%12.43M
-290.37%-1.8M
-Change in prepaid assets
126.43%1.14M
-7,964.29%-2.26M
-170.10%-572K
914.57%3.63M
107.30%341K
-258.94%-4.33M
-102.12%-28K
217.92%816K
-127.91%-446K
-1,037.75%-4.67M
-Change in payables and accrued expense
-370.20%-6.52M
-57.96%1.6M
-160.90%-2.9M
187.63%2.16M
1.42%-7.38M
-187.22%-1.39M
-29.00%3.8M
403.31%4.76M
-252.60%-2.47M
-96.45%-7.48M
-Change in other current liabilities
-10.63%-5.77M
-10.61%-1.48M
-10.60%-1.46M
-10.58%-1.44M
-10.75%-1.39M
-11.16%-5.22M
-10.95%-1.34M
-11.01%-1.32M
-10.98%-1.3M
-11.74%-1.26M
-Change in other working capital
-290.57%-18.84M
-285.99%-8.68M
-65.47%-6.76M
-24.93%-2.93M
-102.52%-467K
162.04%9.88M
-124.34%-2.25M
61.38%-4.08M
-129.95%-2.35M
779.71%18.56M
Cash from discontinued investing activities
Operating cash flow
-51.47%-98.69M
-23.49%-22.15M
-29.31%-31.21M
-142.40%-12.06M
-83.71%-33.29M
39.01%-65.16M
25.31%-17.93M
21.41%-24.13M
73.82%-4.97M
45.30%-18.12M
Investing cash flow
Cash flow from continuing investing activities
83.22%-8.6M
-690.59%-80.73M
2,422.22%4.09M
432.49%38.92M
154.55%29.13M
-132.38%-51.27M
-57.21%13.67M
-99.72%162K
-177.28%-11.71M
-199.75%-53.4M
Net PPE purchase and sale
-237.22%-607K
-375.00%-11K
-3,261.54%-411K
----
----
89.46%-180K
102.55%4K
102.17%13K
45.58%-197K
--0
Net investment purchase and sale
84.35%-7.99M
-690.68%-80.72M
2,918.12%4.5M
439.79%39.11M
154.55%29.13M
-131.92%-51.09M
-57.43%13.67M
-99.74%149K
-174.20%-11.51M
-198.66%-53.4M
Cash from discontinued investing activities
Investing cash flow
83.22%-8.6M
-690.59%-80.73M
2,422.22%4.09M
432.49%38.92M
154.55%29.13M
-132.38%-51.27M
-57.21%13.67M
-99.72%162K
-177.28%-11.71M
-199.75%-53.4M
Financing cash flow
Cash flow from continuing financing activities
178.80%126.4M
105,857.14%118.67M
-26.01%7.77M
0
-100.13%-46K
-0.34%45.34M
-99.81%112K
197.70%10.51M
118.10%135K
5,155.99%34.58M
Net issuance payments of debt
----
----
----
----
----
--0
--0
--0
--0
--0
Net common stock issuance
185.26%126.02M
--118.67M
-26.42%7.5M
--0
-100.46%-155K
-23.26%44.18M
--0
63,825.00%10.2M
--0
36,248.94%33.98M
Proceeds from stock option exercised by employees
-86.25%107K
--0
723.08%107K
--0
--0
1,241.38%778K
--111K
--13K
6,650.00%135K
826.79%519K
Net other financing activities
-28.27%274K
0.00%1K
-44.78%164K
--0
29.76%109K
3.80%382K
200.00%1K
12.93%297K
--0
-19.23%84K
Cash from discontinued financing activities
Financing cash flow
178.80%126.4M
105,857.14%118.67M
-26.01%7.77M
--0
-100.13%-46K
-0.34%45.34M
-99.81%112K
197.70%10.51M
118.10%135K
5,155.99%34.58M
Net cash flow
Beginning cash position
-54.67%58.94M
-1.33%62.25M
6.59%81.6M
-41.21%54.74M
-54.67%58.94M
293.65%130.03M
-2.07%63.09M
58.96%76.56M
76.48%93.1M
293.65%130.03M
Current changes in cash
126.87%19.1M
480.58%15.79M
-43.69%-19.35M
262.37%26.86M
88.61%-4.21M
-173.29%-71.09M
-106.33%-4.15M
-182.79%-13.47M
-260.07%-16.55M
-287.26%-36.93M
End cash Position
32.41%78.05M
32.41%78.05M
-1.33%62.25M
6.59%81.6M
-41.21%54.74M
-54.67%58.94M
-54.67%58.94M
-2.07%63.09M
58.96%76.56M
76.48%93.1M
Free cash flow
-51.98%-99.3M
-23.58%-22.16M
-31.09%-31.62M
-136.74%-12.24M
-83.71%-33.29M
39.81%-65.34M
25.81%-17.93M
22.96%-24.12M
73.29%-5.17M
46.26%-18.12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -51.47%-98.69M-23.49%-22.15M-29.31%-31.21M-142.40%-12.06M-83.71%-33.29M39.01%-65.16M25.31%-17.93M21.41%-24.13M73.82%-4.97M45.30%-18.12M
Net income from continuing operations 0.31%-104.99M40.75%-20.49M-30.41%-32.17M-46.87%-26.02M7.19%-26.32M20.51%-105.32M0.52%-34.57M8.77%-24.67M50.68%-17.72M18.46%-28.36M
Depreciation and amortization 7.76%1.96M-10.83%428K4.07%460K37.28%615K1.79%456K-3.30%1.82M11.63%480K-1.12%442K-2.18%448K-17.80%448K
Other non cash items 1,550.00%99K144.68%21K-3.23%30K-80.53%22K128.57%26K-98.76%6K-9.30%-47K-69.90%31K-47.20%113K-143.75%-91K
Change In working capital -482.87%-29.28M-190.00%-6.68M-78.11%-16.03M23.50%7.25M-511.62%-13.82M210.23%7.65M118.13%7.42M33.31%-9M-37.41%5.87M153.97%3.36M
-Change in receivables -91.94%701K-42.80%4.14M52.68%-4.34M-53.13%5.83M-173.82%-4.93M184.22%8.7M164.06%7.24M-1,837.50%-9.17M2,586.20%12.43M-290.37%-1.8M
-Change in prepaid assets 126.43%1.14M-7,964.29%-2.26M-170.10%-572K914.57%3.63M107.30%341K-258.94%-4.33M-102.12%-28K217.92%816K-127.91%-446K-1,037.75%-4.67M
-Change in payables and accrued expense -370.20%-6.52M-57.96%1.6M-160.90%-2.9M187.63%2.16M1.42%-7.38M-187.22%-1.39M-29.00%3.8M403.31%4.76M-252.60%-2.47M-96.45%-7.48M
-Change in other current liabilities -10.63%-5.77M-10.61%-1.48M-10.60%-1.46M-10.58%-1.44M-10.75%-1.39M-11.16%-5.22M-10.95%-1.34M-11.01%-1.32M-10.98%-1.3M-11.74%-1.26M
-Change in other working capital -290.57%-18.84M-285.99%-8.68M-65.47%-6.76M-24.93%-2.93M-102.52%-467K162.04%9.88M-124.34%-2.25M61.38%-4.08M-129.95%-2.35M779.71%18.56M
Cash from discontinued investing activities
Operating cash flow -51.47%-98.69M-23.49%-22.15M-29.31%-31.21M-142.40%-12.06M-83.71%-33.29M39.01%-65.16M25.31%-17.93M21.41%-24.13M73.82%-4.97M45.30%-18.12M
Investing cash flow
Cash flow from continuing investing activities 83.22%-8.6M-690.59%-80.73M2,422.22%4.09M432.49%38.92M154.55%29.13M-132.38%-51.27M-57.21%13.67M-99.72%162K-177.28%-11.71M-199.75%-53.4M
Net PPE purchase and sale -237.22%-607K-375.00%-11K-3,261.54%-411K--------89.46%-180K102.55%4K102.17%13K45.58%-197K--0
Net investment purchase and sale 84.35%-7.99M-690.68%-80.72M2,918.12%4.5M439.79%39.11M154.55%29.13M-131.92%-51.09M-57.43%13.67M-99.74%149K-174.20%-11.51M-198.66%-53.4M
Cash from discontinued investing activities
Investing cash flow 83.22%-8.6M-690.59%-80.73M2,422.22%4.09M432.49%38.92M154.55%29.13M-132.38%-51.27M-57.21%13.67M-99.72%162K-177.28%-11.71M-199.75%-53.4M
Financing cash flow
Cash flow from continuing financing activities 178.80%126.4M105,857.14%118.67M-26.01%7.77M0-100.13%-46K-0.34%45.34M-99.81%112K197.70%10.51M118.10%135K5,155.99%34.58M
Net issuance payments of debt ----------------------0--0--0--0--0
Net common stock issuance 185.26%126.02M--118.67M-26.42%7.5M--0-100.46%-155K-23.26%44.18M--063,825.00%10.2M--036,248.94%33.98M
Proceeds from stock option exercised by employees -86.25%107K--0723.08%107K--0--01,241.38%778K--111K--13K6,650.00%135K826.79%519K
Net other financing activities -28.27%274K0.00%1K-44.78%164K--029.76%109K3.80%382K200.00%1K12.93%297K--0-19.23%84K
Cash from discontinued financing activities
Financing cash flow 178.80%126.4M105,857.14%118.67M-26.01%7.77M--0-100.13%-46K-0.34%45.34M-99.81%112K197.70%10.51M118.10%135K5,155.99%34.58M
Net cash flow
Beginning cash position -54.67%58.94M-1.33%62.25M6.59%81.6M-41.21%54.74M-54.67%58.94M293.65%130.03M-2.07%63.09M58.96%76.56M76.48%93.1M293.65%130.03M
Current changes in cash 126.87%19.1M480.58%15.79M-43.69%-19.35M262.37%26.86M88.61%-4.21M-173.29%-71.09M-106.33%-4.15M-182.79%-13.47M-260.07%-16.55M-287.26%-36.93M
End cash Position 32.41%78.05M32.41%78.05M-1.33%62.25M6.59%81.6M-41.21%54.74M-54.67%58.94M-54.67%58.94M-2.07%63.09M58.96%76.56M76.48%93.1M
Free cash flow -51.98%-99.3M-23.58%-22.16M-31.09%-31.62M-136.74%-12.24M-83.71%-33.29M39.81%-65.34M25.81%-17.93M22.96%-24.12M73.29%-5.17M46.26%-18.12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -